ECSP972301A - SUBSTITUTED TRICYCLES - Google Patents

SUBSTITUTED TRICYCLES

Info

Publication number
ECSP972301A
ECSP972301A ECSP972301A ECSP972301A EC SP972301 A ECSP972301 A EC SP972301A EC SP972301 A ECSP972301 A EC SP972301A EC SP972301 A ECSP972301 A EC SP972301A
Authority
EC
Ecuador
Prior art keywords
nitrogen
group
sulfur
oxygen
carbon
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Robert D Dillar
Susan E Draheim
John Morin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP972301 priority Critical patent/ECSP972301A/en
Publication of ECSP972301A publication Critical patent/ECSP972301A/en

Links

Landscapes

  • Pyridine Compounds (AREA)

Abstract

El invento se refiere a un compuesto de la fórmula III (gráfico), donde: A es fenilo o piridil donde el nitrógeno está en la posición 5-,6-,7- o 8; uno de B o D es nitrógeno y el otro es carbono; Z es ciclohexenil, fenil, piridil, donde el nitrógeno está en la posición 1-,2- o 3 o un anillo heterocíclico de 6 miembros conteniendo un heterroátomo seleccionado de entre el grupo que consiste en azufre u oxígeno en la posición 1,2 o 3 y nitrógeno en la posición 1-,2-,3-, o 4; es un enlace doble o simple. R20 es seleccionado de entre los grupos (a)(b) y (c) donde ; (a) es -(C5-C20) alquilo, -(C5-C20) alquenil, -(C5-C20) alquini, radicales carbocíclicas o radicales heterocíclicas o (b) es un miembro de (a) sustituído con uno o más sustituyentes que no interfieren independientemente seleccionado; o (c) es el grupo -(L)- R80; donde -(L)- es un grupo de unión divalente de 1 a 12 átomos seleccionados de entre carbono, hidrógeno, oxígeno, nitrógeno y azufre; donde la combinación de átomos en-(L) son seleccionados del grupo que consiste de (i) carbono e hidrógeno solamente, (ii) solamente un azufre, (iii) solamente un oxígeno, (iv) solamente uno o dos nitrógeno e hidrógenos (v) carbono, hidrógeno y azufre solamente y (vi) y cabono, hidrógeno y solamente oxígeno; y donde R80 es un grupo seleccionado de entre (a) o (b); R21 es un sustituyente de no interferencia R1 es -NHNH2 o -NH2; R2 es seleccionada del grupo -OH, -08CH2) tR5 donde R5 es CN o fenil, o (La) - (grupo ácidico), donde -(La)- es un enlasador que tiene un enlasador ácido de longitud de 1 a 7 y t es 1-5; R3 es seleccionado a partir de un sustituyente de no interferencia, radicales carbocíclicos, radicales carbocíclicos sustituidos con sustituyente que no interfieran, radicales heterocíclicos y radicales heterocíclicos sustituídos con sustituyentes que no interfieran; o una sal farmacéuticamente aceptable, racemato, solvato, tautómero somer óptico o derivados prodrogas de esto; provisto de que cuando R3 es H, R20 es bencilo y m es 1 o 2; R2 no puede ser -O(CH2)mH; y cuando D es nitrógeno, el heterroátomo de Z es seleccionado de entre el grupo que consiste de azufre u oxígeno en la posición 1-,2- o 3 y nitrógeno en la posición 1-, 2-, 3 o 4.The invention relates to a compound of formula III (graph), where: A is phenyl or pyridyl where the nitrogen is in the 5-, 6-, 7- or 8-position; one of B or D is nitrogen and the other is carbon; Z is cyclohexenyl, phenyl, pyridyl, where the nitrogen is in the 1-, 2- or 3-position or a 6-membered heterocyclic ring containing a hetero atom selected from the group consisting of sulfur or oxygen in the 1,2-position or 3 and nitrogen at position 1-, 2-, 3-, or 4; it is a double or single bond. R20 is selected from groups (a) (b) and (c) where; (a) is - (C5-C20) alkyl, - (C5-C20) alkenyl, - (C5-C20) alkylin, carbocyclic radicals or heterocyclic radicals or (b) is a member of (a) substituted with one or more substituents they do not interfere independently selected; or (c) is the group - (L) -R80; where - (L) - is a divalent linking group of 1 to 12 atoms selected from carbon, hydrogen, oxygen, nitrogen and sulfur; where the combination of en- (L) atoms are selected from the group consisting of (i) carbon and hydrogen only, (ii) only one sulfur, (iii) only one oxygen, (iv) only one or two nitrogen and hydrogens ( v) carbon, hydrogen and sulfur only and (vi) and carbon, hydrogen and only oxygen; and where R80 is a group selected from (a) or (b); R21 is a non-interference substituent; R1 is -NHNH2 or -NH2; R2 is selected from the group -OH, -08CH2) tR5 where R5 is CN or phenyl, or (La) - (acidic group), where - (La) - is a linker having an acid linker of length 1 to 7 and t is 1-5; R3 is selected from a non-interfering substituent, carbocyclic radicals, non-interfering substituent substituted carbocyclic radicals, heterocyclic radicals, and heterocyclic radicals substituted with non-interfering substituents; or a pharmaceutically acceptable salt, racemate, solvate, someroptic tautomer or prodrug derivatives thereof; provided that when R3 is H, R20 is benzyl and m is 1 or 2; R2 cannot be -O (CH2) mH; and when D is nitrogen, the hetero atom of Z is selected from the group consisting of sulfur or oxygen in position 1-, 2- or 3 and nitrogen in position 1-, 2-, 3 or 4.

ECSP972301 1997-10-30 1997-10-30 SUBSTITUTED TRICYCLES ECSP972301A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP972301 ECSP972301A (en) 1997-10-30 1997-10-30 SUBSTITUTED TRICYCLES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP972301 ECSP972301A (en) 1997-10-30 1997-10-30 SUBSTITUTED TRICYCLES

Publications (1)

Publication Number Publication Date
ECSP972301A true ECSP972301A (en) 1998-12-14

Family

ID=42043130

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP972301 ECSP972301A (en) 1997-10-30 1997-10-30 SUBSTITUTED TRICYCLES

Country Status (1)

Country Link
EC (1) ECSP972301A (en)

Similar Documents

Publication Publication Date Title
CO4920250A1 (en) USEFUL HETERO-CYCLE COMPOUNDS IN THE INHIBITION OF SPLA2
DE69131581D1 (en) 2-oxindole derivatives as tyrosine kinase inhibitors
FR2512024B1 (en)
DE69330351D1 (en) 5-ARYLINDOL DERIVATIVES AND THEIR USE AS SEROTONIN (5-HT1) AGONISTS
EA200100755A1 (en) 4-OXO-1,4-DIHYDRO-3-QUINOLINKARBOXAMIDES AS ANTI-VIRUS AGENTS
NO169437C (en) 3-AMINO-KINO LINER.
EA199800141A1 (en) HETEROCYCLIC COMPOUNDS
DK345989A (en) quinoline
SE8105240L (en) THEOPHYLLINE AND THEOBROMINE DERIVATIVES
PT868182E (en) PROCESS FOR THE PRODUCTION OF PIPERIDINE DERIVATIVES
TR199902897T2 (en) S�v� benz-izo-quinoline t�revleri.
KR950703503A (en) 4-alkoxy-2,6-di-t-butylphenol derivative (4-ALKOXY-2,6-DI-t-BUTYLPHENOL DERIVATVE)
DE69122427D1 (en) Imidazonaphthyridine derivatives
DE69426236D1 (en) Photochrome heterocyclochromene
MX9301045A (en) PROCEDURE FOR PREPARING FIBRINOGEN RECEIVING ANTAGONISTS.
DK304289A (en) BENZ DERIVATIVES
ATE140001T1 (en) ISOCHROMAN DERIVATIVES
DE69910568D1 (en) FUROPYRIDINE DERIVATIVES AND THEIR THERAPEUTIC USE
ECSP972301A (en) SUBSTITUTED TRICYCLES
ATE202103T1 (en) 6-AZAINDOLE INHIBITORS OF TROMBOXANE SYNTHETASE
ES455909A1 (en) 1,4-Substituted piperazinyl derivatives useful as psychostimulants
CO4940478A1 (en) DERIVATIVES OF 1- (2-ACILIMIDAZOL-1-ILALQUIL) QUINUCLIDINO
DE3667977D1 (en) TRICYCLIC DERIVATIVES OF THIADIAZOLOXIDES.
DK316589A (en) SUBSTITUTED AZACYCLOHEXYL DERIVATIVES OF RIFAMYCINES
FI811266L (en) ANTIHYPERTENSIVE LACTAMER